Personalizing care within the MDT for patients with early through to advanced RCC

touchFOCUS for touchONCOLOGY

Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communication strategies and shared decision-making when managing diverse and/or underserved populations with RCC.

The expert

• Prof. Hans Hammers, UT Southwestern, Dallas, TX, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/